title: Successful treatment of epidermal growth factor receptor inhibitor-induced periungual inflammation with adapalene.
abstract: Epidermal growth factor receptor (EGFR) inhibitors are increasingly used for cancer treatment, but commonly carry dermatologic side effects. Periungual inflammation is a particularly painful condition that additionally worsens quality of life. In this paper, we report 3 cases of successful treatment of periungual inflammation induced by 3 different EGFR inhibitors (gefitinib, erlotinib, and cetuximab) with topically applied adapalene.
authors: Karatsu Red Cross Hospital, Karatsu, School of Medical Sciences, Kyushu University, Fukuoka, Japan.
authors: Junichi
authors: J
authors: Hachisuka
authors: Kazuko
authors: K
authors: Doi
authors: Yoichi
authors: Y
authors: Moroi
authors: Masutaka
authors: M
authors: Furue